Tilos Therapeutics

About:

Tilos Therapeutics is a product-focused company that creates anti-LAP antibodies for cancer treatment.

Website: https://www.tilostherapeutics.com

Top Investors: ShangPharma Innovation

Description:

Tilos Therapeutics is developing antibody therapeutics that target key immunological pathways, with a primary focus on regulatory T cells and regulation of effector cells. The company's initial work is on antibodies specific for Latency Associated Peptide of TGF beta. Tilos was founded in 2016 and is based in Cambridge, Massachusetts.

Total Funding Amount:

$3.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Lexington, Massachusetts, United States

Founded Date:

2016-01-01

Contact Email:

bfox(AT)tilostherapeutics.com

Founders:

Barbara S. Fox, Jonathan Behr

Number of Employees:

11-50

Last Funding Date:

2017-09-21

IPO Status:

Private

Industries: